BN
Bose Namburi
About Bose Namburi
Data last updated:
Bose Namburi is a Whole-Time Director at Hetero Healthcare Limited (since 2016), Director at Azista Industries Private Limited (since 2017) and Additional Director at Sri Sai Ashirwaad Enterprises Private Limited (since 2025), and holds 1 more current directorship. The companies operate in Pharma, Transport and Logistics and Trading. The 3 current companies with reported revenue have a combined latest revenue of ₹1,370 Cr; the largest is Hetero Healthcare Limited at ₹1,190 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Hetero Healthcare Limited U52520TG2006PLC049614 | Whole-Time Director | 15 Dec 2016 | 2006 | ₹1,190 Cr (FY 2025) | Active |
 Azista Industries Private Limited U29100TG2014PTC096797 | Director | 25 Apr 2017 | 2014 | ₹162 Cr (FY 2025) | Active |
 Sri Sai Ashirwaad Enterprises Private Limited U74999TG2007PTC056072 | Additional Director | 06 Oct 2025 | 2007 | ₹18.81 Cr (FY 2025) | Active |
| Alestra Infraprojects Private Limited U43900TS2023PTC171537 | Director | 03 Apr 2023 | 2023 | Active |
Board colleagues of Bose Namburi
| Name | DIN | Company | Designation |
|---|---|---|---|
| Bandi Vamsikrishna | 01014619 | Hetero Healthcare Limited | Director |
| Kalavathi Bandi | 00194597 | Hetero Healthcare Limited | Director |
| Parthasaradhi Reddy Bandi | 00015899 | Hetero Healthcare Limited | Director |
| Ramaseshappa Siva Prasad Panchangam | 09447160 | Hetero Healthcare Limited | Director |
| Santosh Babu Busani | 09097558 | Hetero Healthcare Limited | Director |
| Srinivas Reddy Male | 00016085 | Hetero Healthcare Limited , Azista Industries Private Limited and 1 more | Managing Director |
| Ravi Chandra Reddy Reddy Vaka | 07545310 | Azista Industries Private Limited | Director |
| Chittajallu Gopalakrishna | 07757879 | Sri Sai Ashirwaad Enterprises Private Limited | Additional Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Bose Namburi
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Bose Namburi
Bose Namburi currently holds 4 directorships: Hetero Healthcare Limited (Whole-Time Director, since 15 Dec 2016, revenue ₹1,190 Cr (FY 2025)); Azista Industries Private Limited (Director, since 25 Apr 2017, revenue ₹162 Cr (FY 2025)); Sri Sai Ashirwaad Enterprises Private Limited (Additional Director, since 06 Oct 2025, revenue ₹18.81 Cr (FY 2025)); Alestra Infraprojects Private Limited (Director, since 03 Apr 2023).
Bose Namburi was first appointed on 15 Dec 2016 as Whole-Time Director at Hetero Healthcare Limited. The most recent appointment on record is 06 Oct 2025 at Sri Sai Ashirwaad Enterprises Private Limited.
The 3 current companies of Bose Namburi that report revenue have a combined latest revenue of ₹1,370 Cr: Hetero Healthcare Limited ₹1,190 Cr (FY 2025); Azista Industries Private Limited ₹162 Cr (FY 2025); Sri Sai Ashirwaad Enterprises Private Limited ₹18.81 Cr (FY 2025).
The current boards of Bose Namburi's companies include Bandi Vamsikrishna (Hetero Healthcare Limited), Kalavathi Bandi (Hetero Healthcare Limited), Parthasaradhi Reddy Bandi (Hetero Healthcare Limited), Ramaseshappa Siva Prasad Panchangam (Hetero Healthcare Limited), Santosh Babu Busani (Hetero Healthcare Limited), Srinivas Reddy Male (Hetero Healthcare Limited), among others.